---
title: "Latest-generation Evolut TAVI system gains US FDA approval"
date: "2024-03-27T14:09:01.000Z"
publishedDate: "27 mars 2024"
summary: "Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Evolut FX+ transcatheter aortic valve implantation (TAVI) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVI system maintains the valve performance of the legacy Evolut TAVI platform and is designed to facilitate coronary access."
importance: ""
sourceUrl: "https://cardiovascularnews.com/latest-generation-evolut-tavi-system-gains-us-fda-approval/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-03-27-latest-generation-evolut-tavi-system-gains-us-fda-approval"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/Medtronic_EV_FX__23_Profile_A-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/latest-generation-evolut-tavi-system-gains-us-fda-approval/"
---

![Latest-generation Evolut TAVI system gains US FDA approval](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/Medtronic_EV_FX__23_Profile_A-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/latest-generation-evolut-tavi-system-gains-us-fda-approval/*

## L’essentiel

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Evolut FX+ transcatheter aortic valve implantation (TAVI) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVI system maintains the valve performance of the legacy Evolut TAVI platform and is designed to facilitate coronary access.

## Lien source

https://cardiovascularnews.com/latest-generation-evolut-tavi-system-gains-us-fda-approval/
